{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:36:16Z","timestamp":1786548976934,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Obesity remains a major global health challenge, driving demand for effective pharmacotherapies. Cagrilintide, a once-weekly amylin receptor agonist, and its fixed-dose combination with semaglutide (CagriSema) represent novel therapeutic approaches. This systematic review and meta-analysis evaluated their efficacy and safety in adults with overweight or obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Four databases were searched from inception to March 2026. Eligible randomized controlled trials (RCTs) assessed Cagrilintide monotherapy or CagriSema versus placebo. Outcomes included percentage and absolute body weight change, waist circumference, blood pressure, HbA1c, and adverse events. Data were pooled using random-effects models in RevMan, with results expressed as mean differences (MD) or risk ratios (RR) with 95% confidence intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Four RCTs encompassing 5425 participants were included. Cagrilintide monotherapy produced significant reductions in body weight (MD:\u00a0\u22126.08%; MD:\u00a0\u22125.89 kg) and blood pressure, without meaningful HbA1c improvement. CagriSema significantly reduced body weight (MD:\u00a0\u22125.98%; MD:\u00a0\u22124.68 kg), waist circumference (MD:\u00a0\u221210.91 cm), systolic blood pressure, and HbA1c. Both treatments showed modest but statistically significant increases in adverse events. Substantial heterogeneity was observed across most outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cagrilintide-based therapies produce clinically meaningful weight loss and cardiometabolic improvements. CagriSema demonstrates additional glycemic benefits over monotherapy. Larger, longer-duration trials are needed to confirm long-term efficacy and safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000005353","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:03:31Z","timestamp":1786539811000},"page":"5317-5326","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Amylin-based obesity therapy: a meta-analysis of Cagrilintide and CagriSema versus placebo"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8847-8747","authenticated-orcid":false,"given":"Mohammad","family":"Yaseen","sequence":"first","affiliation":[{"name":"Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akmal","family":"Ameer","sequence":"additional","affiliation":[{"name":"University Hospital Limerick, Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfiqar","family":"Ali","sequence":"additional","affiliation":[{"name":"Chandka Medical College, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil Ahmed","family":"Jamali","sequence":"additional","affiliation":[{"name":"University Hospital Limerick, Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Chandka Medical College, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8504-5109","authenticated-orcid":false,"given":"Muhammad","family":"Basit Ali Siddiqui","sequence":"additional","affiliation":[{"name":"Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8872-5095","authenticated-orcid":false,"given":"Payal","family":"Kumari","sequence":"additional","affiliation":[{"name":"Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hassaan","sequence":"additional","affiliation":[{"name":"Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4822-1448","authenticated-orcid":false,"given":"Pooja","family":"Nanwani","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6242-285X","authenticated-orcid":false,"given":"Muhammad","family":"Abdul Basit","sequence":"additional","affiliation":[{"name":"Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimerta","family":"Lohana","sequence":"additional","affiliation":[{"name":"Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4574-9651","authenticated-orcid":false,"given":"Rehan","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahir","family":"Tesfaye","sequence":"additional","affiliation":[{"name":"Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"R1-20260812","doi-asserted-by":"crossref","first-page":"1027\u201350","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"R2-20260812","first-page":"13\u201327","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"key":"R3-20260812","doi-asserted-by":"crossref","first-page":"342\u201362","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20260812","doi-asserted-by":"crossref","first-page":"989\u20131002","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"R5-20260812","doi-asserted-by":"crossref","first-page":"205\u201316","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"R6-20260812","doi-asserted-by":"crossref","first-page":"83\u201390","DOI":"10.1097\/CRD.0000000000000513","article-title":"Cagrilintide: a long-acting amylin analog for the treatment of obesity","volume":"32","author":"D\u2019ascanio","year":"2024","journal-title":"Cardiol Rev"},{"key":"R7-20260812","doi-asserted-by":"crossref","first-page":"1736\u201348","DOI":"10.1016\/S0140-6736(21)00845-X","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2\u00b74 mg for weight management: a randomised, controlled, phase 1b trial","volume":"397","author":"Enebo","year":"2021","journal-title":"Lancet"},{"key":"R8-20260812","doi-asserted-by":"crossref","first-page":"5556\u201389","DOI":"10.1111\/dom.70822","article-title":"Beyond GLP -1 monotherapy: novel multi-agonists, amylin analogues, and combination strategies in obesity and type 2 diabetes","volume":"28","author":"Khachaturov","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"R9-20260812","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"R10-20260812","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R11-20260812","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.71049","article-title":"Efficacy and safety of nerinetide in acute ischemic stroke patients: a systematic review, meta-analysis and meta regression","volume":"15","author":"Khurram","year":"2025","journal-title":"Brain Behav"},{"key":"R12-20260812","doi-asserted-by":"crossref","DOI":"10.70389\/PJS.100082","article-title":"Transparency in the reporting of Artificial INtelligence \u2013 the TITAN guideline","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R13-20260812","first-page":"e172","article-title":"Efficacy and safety of sotatercept in pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"33","author":"Kumar","year":"2026","journal-title":"Am J Ther"},{"key":"R14-20260812","doi-asserted-by":"crossref","first-page":"557\u201360","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"R15-20260812","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70217","article-title":"Comparative efficacy and safety of ecnoglutide in type 2 diabetes: a systematic review and meta-analysis","volume":"9","author":"Kumar","year":"2026","journal-title":"Endocrinol Diabetes Metab"},{"key":"R16-20260812","doi-asserted-by":"crossref","DOI":"10.1111\/bph.70484","article-title":"Amylin analogues as a novel perspective in anti-obesity therapy","author":"Lutz","year":"2026","journal-title":"Br J Pharmacol"},{"key":"R17-20260812","doi-asserted-by":"crossref","first-page":"635\u201347","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"N Engl J Med"},{"key":"R18-20260812","doi-asserted-by":"crossref","first-page":"648\u201359","DOI":"10.1056\/NEJMoa2502082","article-title":"Cagrilintide-semaglutide in adults with overweight or obesity and type 2 diabetes","volume":"393","author":"Davies","year":"2025","journal-title":"N Engl J Med"},{"key":"R19-20260812","article-title":"Tirzepatide versus semaglutide for weight loss in overweight and obese adults: a systematic review and meta-analysis of direct comparative studies","volume":"17","author":"Munawar","year":"2025","journal-title":"Cureus"},{"key":"R20-20260812","first-page":"285\u201396","article-title":"Comparative efficacy of tirzepatide vs. semaglutide in reducing body weight in humans: a systematic review and meta-analysis of clinical trials and real-world data","volume":"17","author":"Bin","year":"2025","journal-title":"J Clin Med Res"},{"key":"R21-20260812","doi-asserted-by":"crossref","first-page":"177\u201389","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R22-20260812","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11906-026-01374-7","article-title":"Should incretin agonist-based brugs be considered for first line antihypertensive therapy?","volume":"28","author":"Wenzel","year":"2026","journal-title":"Curr Hypertens Rep"},{"key":"R23-20260812","doi-asserted-by":"crossref","DOI":"10.1007\/s40200-025-01853-9","article-title":"Impact of oral magnesium supplementation on glycemic and cardiometabolic outcomes in prediabetic adults: a systematic review and meta-analysis","volume":"25","author":"Basit","year":"2026","journal-title":"J Diabetes Metab Disord"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:35:04Z","timestamp":1786545304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000005353","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"2025-12-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}